332 related articles for article (PubMed ID: 26863209)
61. Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
Mushaben EM; Hershey GK; Pauciulo MW; Nichols WC; Le Cras TD
PLoS One; 2012; 7(3):e32468. PubMed ID: 22427841
[TBL] [Abstract][Full Text] [Related]
62. Potential role of cartilage oligomeric matrix protein in the modulation of pulmonary arterial smooth muscle superoxide by hypoxia.
Yu H; Alruwaili N; Hu B; Kelly MR; Zhang B; Sun D; Wolin MS
Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L569-L577. PubMed ID: 31389735
[TBL] [Abstract][Full Text] [Related]
63. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
[TBL] [Abstract][Full Text] [Related]
64. A Potential Role for Exosomal Translationally Controlled Tumor Protein Export in Vascular Remodeling in Pulmonary Arterial Hypertension.
Ferrer E; Dunmore BJ; Hassan D; Ormiston ML; Moore S; Deighton J; Long L; Yang XD; Stewart DJ; Morrell NW
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):467-478. PubMed ID: 29676587
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
Li L; Wei C; Kim IK; Janssen-Heininger Y; Gupta S
Hypertension; 2014 Jun; 63(6):1260-9. PubMed ID: 24614212
[TBL] [Abstract][Full Text] [Related]
66. Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
Flynn C; Zheng S; Yan L; Hedges L; Womack B; Fessel J; Cogan J; Austin E; Loyd J; West J; Zhao Z; Hamid R
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):20-7. PubMed ID: 22312021
[TBL] [Abstract][Full Text] [Related]
67. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
68. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies.
Newman JH; Phillips JA; Loyd JE
Ann Intern Med; 2008 Feb; 148(4):278-83. PubMed ID: 18283205
[TBL] [Abstract][Full Text] [Related]
69. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.
Gu M; Shao NY; Sa S; Li D; Termglinchan V; Ameen M; Karakikes I; Sosa G; Grubert F; Lee J; Cao A; Taylor S; Ma Y; Zhao Z; Chappell J; Hamid R; Austin ED; Gold JD; Wu JC; Snyder MP; Rabinovitch M
Cell Stem Cell; 2017 Apr; 20(4):490-504.e5. PubMed ID: 28017794
[TBL] [Abstract][Full Text] [Related]
70. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
[TBL] [Abstract][Full Text] [Related]
71. PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by
Shimizu T; Higashijima Y; Kanki Y; Nakaki R; Kawamura T; Urade Y; Wada Y
Sci Signal; 2021 Jan; 14(667):. PubMed ID: 33500333
[TBL] [Abstract][Full Text] [Related]
72. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
Hemnes AR; Brittain EL; Trammell AW; Fessel JP; Austin ED; Penner N; Maynard KB; Gleaves L; Talati M; Absi T; Disalvo T; West J
Am J Respir Crit Care Med; 2014 Feb; 189(3):325-34. PubMed ID: 24274756
[TBL] [Abstract][Full Text] [Related]
73. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
74. Single-cell RNA sequencing reveals that
Du M; Jiang H; Liu H; Zhao X; Zhou Y; Zhou F; Piao C; Xu G; Ma F; Wang J; Perros F; Morrell NW; Gu H; Yang J
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34857612
[TBL] [Abstract][Full Text] [Related]
75. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.
McMurtry MS; Moudgil R; Hashimoto K; Bonnet S; Michelakis ED; Archer SL
Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L872-8. PubMed ID: 17142350
[TBL] [Abstract][Full Text] [Related]
76. Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Chen X; Austin ED; Talati M; Fessel JP; Farber-Eger EH; Brittain EL; Hemnes AR; Loyd JE; West J
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775043
[TBL] [Abstract][Full Text] [Related]
77. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
[TBL] [Abstract][Full Text] [Related]
78. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
79. Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene.
Park SH; Chen WC; Hoffman C; Marsh LM; West J; Grunig G
PLoS One; 2013; 8(1):e55180. PubMed ID: 23383100
[TBL] [Abstract][Full Text] [Related]
80. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
Evans JD; Girerd B; Montani D; Wang XJ; Galiè N; Austin ED; Elliott G; Asano K; Grünig E; Yan Y; Jing ZC; Manes A; Palazzini M; Wheeler LA; Nakayama I; Satoh T; Eichstaedt C; Hinderhofer K; Wolf M; Rosenzweig EB; Chung WK; Soubrier F; Simonneau G; Sitbon O; Gräf S; Kaptoge S; Di Angelantonio E; Humbert M; Morrell NW
Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
